Congenital adrenal hyperplasia—current insights in pathophysiology, diagnostics, and management

HL Claahsen-van der Grinten, PW Speiser… - Endocrine …, 2022 - academic.oup.com
Congenital adrenal hyperplasia (CAH) is a group of autosomal recessive disorders affecting
cortisol biosynthesis. Reduced activity of an enzyme required for cortisol production leads to …

Acute fatty liver disease of pregnancy: updates in pathogenesis, diagnosis, and management

J Liu, TT Ghaziani, JL Wolf - … journal of the American College of …, 2017 - journals.lww.com
Acute fatty liver of pregnancy (AFLP) is an obstetric emergency characterized by maternal
liver failure and may have complications for the mother and fetus, including death. This …

Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice guideline

PW Speiser, W Arlt, RJ Auchus… - The Journal of …, 2018 - academic.oup.com
Objective To update the congenital adrenal hyperplasia due to steroid 21-hydroxylase
deficiency clinical practice guideline published by the Endocrine Society in 2010 …

Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline

PW Speiser, R Azziz, LS Baskin… - The Journal of …, 2010 - academic.oup.com
Objective: We developed clinical practice guidelines for congenital adrenal hyperplasia
(CAH). Participants: The Task Force included a chair, selected by The Endocrine Society …

Rare disease, advocacy and justice: Intersecting disparities in research and clinical care

MC Halley, CME Halverson, HK Tabor… - The American Journal …, 2023 - Taylor & Francis
Rare genetic diseases collectively impact millions of individuals in the United States. These
patients and their families share many challenges including delayed diagnosis, lack of …

Neonatal screening for congenital adrenal hyperplasia

PC White - Nature Reviews Endocrinology, 2009 - nature.com
Congenital adrenal hyperplasia (CAH) caused by steroid 21-hydroxylase deficiency occurs
in 1: 16,000–1: 20,000 births. If not promptly diagnosed and treated, CAH can cause death …

Inborn errors of metabolism identified via newborn screening: Ten-year incidence data and costs of nutritional interventions for research agenda planning

BL Therrell Jr, MA Lloyd-Puryear, KM Camp… - Molecular genetics and …, 2014 - Elsevier
Inborn errors of metabolism (IEM) are genetic disorders in which specific enzyme defects
interfere with the normal metabolism of exogenous (dietary) or endogenous protein …

Induction of labor at 39 weeks of gestation versus expectant management for low-risk nulliparous women: a cost-effectiveness analysis

AR Hersh, AE Skeith, JA Sargent… - American journal of …, 2019 - Elsevier
Background A large, recent multicenter trial found that induction of labor at 39 weeks for low-
risk nulliparous women was not associated with an increased risk of cesarean delivery or …

Population screening for genetic disorders in the 21st century: evidence, economics, and ethics

SD Grosse, WH Rogowski, LF Ross, MC Cornel… - Public health …, 2009 - karger.com
Background: Proposals for population screening for genetic diseases require careful
scrutiny by decision makers because of the potential for harms and the need to demonstrate …

[HTML][HTML] Main report

MS Watson, MA Lloyd-Puryear, MY Mann, P Rinaldo… - Genetics in …, 2006 - Elsevier
Background States vary widely in their use of newborn screening tests, with some
mandating screening for as few as three conditions and others mandating as many as 43 …